Inventor

Stanislaw Pikul

Inventor
Mason, OH, US

Overview

28→
Patents
1995–2015
Patent span
Chemistry
Primary field (CPC C)

Patents· 28 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07CAcyclic or carbocyclic compounds14%
A61KPreparations for medical, dental or toiletry purposes9%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
Y02PClimate change mitigation technologies in the production or processing of goods3%
C07HSugars1%
C07JSteroids1%
PatentTitleYear
9,095,575'Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents'20158,981,114'Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents'20157,094,791'Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof'20066,949,545'Heterocyclic side chain containing, n-substituted metalloprotease inhibitors'20056,872,742'Substituted cyclic amine metalloprotease inhibitors'20056,858,628'Substituted cyclic amine metalloprotease inhibitors'20056,852,751'Difluorobutyric acid metalloprotease inhibitors'20056,762,198'Dihetero-substituted metalloprotease inhibitors'20046,696,456'Beta disubstituted metalloprotease inhibitors'20046,569,855'Substituted cyclic amine metalloprotease inhibitors'20036,566,381'Hetero-substituted metalloprotease inhibitors'20036,548,539'Agents for regulation of colon cancer gene expression'20036,545,038'Heterocyclic metalloprotease inhibitors'20036,469,000'1,3-diheterocyclic metalloprotease inhibitors'20026,465,474'1,3-diheterocyclic metalloprotease inhibitors'20026,417,219'Hetero-substituted cyclic amine metalloprotease inhibitors'20026,399,598'Diheterocyclic metalloprotease inhibitors'20026,329,418'Substituted pyrrolidine hydroxamate metalloprotease inhibitors'20016,218,389'Acyclic metalloprotease inhibitors'20016,197,770'Alkenyl- and alkynl-containing metalloprotease inhibitors'20016,166,005'Heterocyclic metalloprotease inhibitors'20006,150,370'1,3-diheterocyclic metalloprotease inhibitors'20006,121,258'1,5-heterocyclic metalloprotease inhibitors'20006,015,912'Spirocyclic containing hydroxamic acids useful as metalloprotease inhibitors'20005,830,915'Phosphinic acid amides as matrix metalloprotease inhibitors'19985,591,836'Cholesterol lowering compounds'19975,510,361'Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents'19965,476,876'Di-tert-butylphenol compounds useful as anti-inflammatory agents'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–2005Patents assigned to PROCTER & GAMBLE (24)· patent assignee history
1995–1997Based in Cincinnati, OH, US· patent location history
1998–2005Based in Mason, OH, US· patent location history
2003–2006Patents assigned to AVALON PHARMACEUTICALS (2)· patent assignee history
2003–2006Based in Germantown, MD, US· patent location history
2015Patents assigned to ONCOARENDI THERAPEUTICS SP Z O O (2)· patent assignee history
2015Based in Jaslo, PL· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
PROCTER & GAMBLE241995–2005
AVALON PHARMACEUTICALS22003–2006
ONCOARENDI THERAPEUTICS SP Z O O22015
Locations
LocationPatentsSpan
Mason, OH, US181998–2005
Germantown, Maryland, US52003–2006
Cincinnati, OH, US31995–1997
Jaslo, PL22015